Imunon IMNN
NASDAQ IMNN
$1.28 -0.04 (-3.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Imunon (IMNN) Non Operating Investment Income (2018 - 2019)

Updated

Imunon (IMNN) recorded Non Operating Investment Income of $58,068 in Q3 2019, compared with $2,788 a year earlier.

Analysis

Imunon (IMNN) Non Operating Investment Income (2018 - 2019) Analysis & Trends

On a TTM basis, Imunon's Non Operating Investment Income came in at $71,206 as of Sep 30, 2019.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Imunon 5.97 Mn 5.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 58,068.00
Jun 30, 2019 969.00
Mar 31, 2019 9,381.00
Sep 30, 2018 2,788.00
Jun 30, 2018 3,902.00
Mar 31, 2018 4,435.00
API Access

Imunon Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=IMNN&period=max&api_key=YOUR_API_KEY